- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03363386
Effects Of Resistive Exercise or Proprioceptive Exercise Training Among Patients With Type 2 Diabetes Mellitus
December 5, 2017 updated by: Yeditepe University
Effects oF Resistive Exercise or Proprioceptive Exercise Training on Balance and Superficial Sense of Patients With Type 2 Diabetes Mellitus
The aim of the study is to investigate proprioceptive exercises training combined with aerobic exercises and resistive exercises training combined with aerobic exercises on dynamic balance and superficial sense.
The patients were randomly divided into Proprioceptive Exercise Training Group (PG) (n=15) and Resistive Exercise Training Group (RG) (n=15).
All subjects were included exercise education program and both groups had trained aerobic exercise program for walking on treadmill (2times/wk.
6 week duration).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The aim of the study is to investigate proprioceptive exercises training combined with aerobic exercises and resistive exercises training combined with aerobic exercises on dynamic balance and superficial sense.
The study included 30 volunteers with Type 2 Diabetes Mellitus(T2DM) who were referred to Fitness Center Arif Nihat Asya Kültür Merkezi Istanbul, Turkey by a medical doctor between December 2016- March 2017 and got diagnosed and followed up at least 6 month before.
Glycemic control of all the participants were assessed according to fasting blood glucose and glycolated hemoglobin (HbA1c).
Waist and hip circumference was recorded in centimeters.
Six minute walking test (6MWT) was used to determine functional capacity of participants.
We evaluated the dynamic balance of patients by Prokin PK200, Italy.
Five parameters were obtained from Prokin as; Perimeter Length (PL), Area gap percentade (AGP) Medium Speed (MS), Anteroposterior equilibrium (AP) and Mediolateral equilibrium (ML).
Proprioception assessment was done with angle reproduction test in direction of dorsiflexion and plantar flexion and deviations were recorded.
Superficial sense was assessed with two point discrimination test and vibration threshold was evaluated by biothesiometer.
Lower extremity muscles strength were assessed with handheld dynamometer (PowerTrack II commander, JTech Medical, Midvale, UT).
The patients were randomly divided into Proprioceptive Exercise Training Group (PG) and Resistive Exercise Training Group (RG).
All subjects were included exercise education program and both groups had trained aerobic exercise program for walking on treadmill (2times/wk.
6 week duration).
The proprioceptive exercise program was applied in PG and the resistive exercise program was applied in RG twice a week and for duration 6 week.
Study Type
Interventional
Enrollment (Actual)
33
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 60 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Participating to the study in a voluntary basis
- Patients with 30-60 years old
- Getting diagnosed with Type 2 Diabetes Mellitus (DM) at least 6 months.
Exclusion Criteria:
- Unstable cardiac condition
- Uncontrolled Diabetes Mellitus
- Uncontrolled Hypertension
- Symptomatic Heart Failure, unstable angina
- Peripheral Arterial Occlusive Disease
- Diabetic foot ulcers
- Part/total foot amputation
- Myocardial infarction within 3 months prior to study
- Coronary Artery Bypass within 3 months prior to study
- Cerebrovascular ischemia/stroke (including TIA) within 3 months of study
- Severe retinopathy, nephropathy
- Thyroid Dysfunctions (hyperthyroidism, hypothyroidism).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Proprioceptive Exercise Group (PG)
Aerobic Exercise Proprioceptive Exercises
|
Patients trained for proprioceptive exercises
Patients were educated with treadmill walking for 30 minutes of each exercise session
|
Active Comparator: Resistive Exercise Group (RG)
Aerobic Exercise Resistive Exercises
|
Patients were educated with treadmill walking for 30 minutes of each exercise session
Patients trained for resistive exercises
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in HbA1c level
Time Frame: 6 weeks
|
It was evaluated for metabolic control with patient's routine controls in their clinics follow-up.
At the end of the study, this metabolic variable was evaluated again in order to observe changes
|
6 weeks
|
Waist and Hip Circumferences
Time Frame: 6 weeks
|
It represents risks for cardiovascular diseases.
|
6 weeks
|
Six minute walking test
Time Frame: 6 weeks
|
Functional capacity of the patients was evaluated through 6 minute walking test
|
6 weeks
|
Dynamic balance assessment
Time Frame: 6 weeks
|
Prokin PK 200 was used for dynamic balance assessment
|
6 weeks
|
Vibration Perception Threshold Assessment
Time Frame: 6 weeks
|
Biothesiometer was used for determining vibration perception threshold
|
6 weeks
|
Lower Extremity Muscle Strength
Time Frame: 6 weeks
|
Commander myometer was used for muscle strength assessment
|
6 weeks
|
Proprioception Assesment
Time Frame: 6 weeks
|
Angle reproduction test was used
|
6 weeks
|
Two Point Discrimination Test
Time Frame: 6 weeks
|
aesthesiometer was used to determine two point discrimination sensation
|
6 weeks
|
Change in fasting blood glucose level
Time Frame: 6 weeks
|
It was evaluated for metabolic control with patient's routine controls in their clinics follow-up.
At the end of the study, this metabolic variable was evaluated again in order to observe changes
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Guzin Kaya Aytutuldu, M.Sc., Yeditepe University, Health Sciences Faculty, Department of Physiotherapy and Rehabilitation
- Study Chair: Gülgün Arslan, MD, Istanbul Pendik Kaynarca Outpatient Policlinic Diabetes Center
- Study Chair: Elif Develi, M.Sc., Yeditepe University, Health Sciences Faculty, Department of Physiotherapy and Rehabilitation
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2016
Primary Completion (Actual)
January 1, 2017
Study Completion (Actual)
March 1, 2017
Study Registration Dates
First Submitted
November 10, 2017
First Submitted That Met QC Criteria
December 5, 2017
First Posted (Actual)
December 6, 2017
Study Record Updates
Last Update Posted (Actual)
December 6, 2017
Last Update Submitted That Met QC Criteria
December 5, 2017
Last Verified
December 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Yeditepe U
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes Mellitus
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Dexa Medica GroupCompletedType-2 Diabetes MellitusIndonesia
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
AstraZenecaRecruiting
Clinical Trials on Proprioceptive Exercises
-
University of MalagaNot yet recruitingShoulder Pain | Wrist Fractures
-
University of Sao PauloCompletedQuality of Life | Shoulder Impingement Syndrome | SatisfactionBrazil
-
University of MalagaRecruiting
-
University of MalagaNot yet recruitingPain | Wrist Fractures
-
University of MalagaCompletedProprioceptive Thumb Exercises Program in Patients With Carpometacarpal Joint Osteoarthritis (thumb)Thumb OsteoarthritisSpain
-
Universidade Estadual de LondrinaCompleted
-
Kafrelsheikh UniversityCompletedPregnancy | Balance | Disturbance
-
Clinica Universitaria Reina Fabiola, Universidad...RecruitingThumb OsteoarthritisArgentina, Spain
-
Riphah International UniversityCompleted
-
Cairo UniversityRecruitingShoulder Pain | Shoulder ImpingementEgypt